Tag: experience

Starting 16th June, L50s Pro Ultra and L50 Ultra CE will be available on Amazon India, Dreame Technology India website, Croma, and select retail...

They faced everything Everest could throw at them: bone-deep cold, unstable ice in the notorious Khumbu Icefall, and the shadow of tragedy that hung...

BEIJING, June 16, 2026 /PRNewswire/ -- Reading the news about the just concluded Second World Conference of Classics in Athens reminds me of my...

They faced everything Everest could throw at them: bone-deep cold, unstable ice in the notorious Khumbu Icefall, and the shadow of tragedy that hung...

MUMBAI, India, June 16, 2026 /PRNewswire/ -- InCred Capital, the institutional, wealth and asset management arm of InCred Group, today announced the launch of...

SINGAPORE, June 16, 2026 /PRNewswire/ -- Today, Arcfra announces the release of Arcfra Kubernetes Engine (AKE) version 1.6, the latest version of its production-grade container management...

77% of participants rated Tiger Beer as "excellent" or "very good" before knowing it was Tiger, reinforcing the beer's world-class quality on taste alone.SINGAPORE,...

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering price of $3.75 per share. All ordinary shares to be sold in the Offering will be offered by Alvotech. The Offering is expected to close on or about June 17, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 3,400,000 ordinary shares at the public offering price, less underwriting discounts and commissions. Before deducting the underwriting discounts and commissions and offering expenses, the Company expects to receive total gross proceeds of approximately $85 million from the Offering, or approximately $98 million if the underwriters exercise in full their option to purchase additional shares.

KUALA LUMPUR, Malaysia, June 16, 2026 /PRNewswire/ -- Amaron, the flagship battery brand from Amara Raja Energy & Mobility Limited, is set to strengthen its...

Rhode Island Becomes Zum's 18th State as Company Expands Northeast PresenceREDWOOD CITY, Calif., June 15, 2026 /PRNewswire/ -- Scituate School Department and Johnston Public...

MORGANTOWN, W.Va., June 15, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Haider Jaffrey, DDS is acknowledged as a Pinnacle Lifetime Member for his...

NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regencell Bioscience Holdings Limited (NASDAQ: RGC) between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”), of the important June 23, 2026 lead plaintiff deadline.

AI strategies automatically execute trades, with XRP settling daily on time, completely eliminating the need for manual monitoring.

AI strategies automatically execute trades, with XRP settling daily on time, completely eliminating the need for manual monitoring.